Ocular Findings Before and After Pegylated Interferon Treatment in Chronic Hepatitis B and C Patients

Creative Commons License

Kose Ş., Turken M., Kuzucu L., Ture G., Orsel T.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.20, sa.1, ss.1-3, 2014 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 1
  • Basım Tarihi: 2014
  • Doi Numarası: 10.4274/vhd.35229
  • Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1-3
  • Anahtar Kelimeler: Hepatit B, hepatit C, pegile-interferon-alfa, retinopati
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Objective: Interferons are used in the treatments of chronic hepatitis B and C since they inhibit viral replication and have immunomodulatory effects. Common side effects include: flu-like syndrome, hematologic abnormalities, cardiovascular system and gastrointestinal system symptoms, diabetes, autoimmune disorders, pulmonary dysfunction, and suffering from depression. In this study, the development of retinopathy, a rare side effect of interferon, was aimed to be investigated.